Drug Trial Radar · NCT05371613
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)
Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
65
Actual
Start
Jul 21, 2022
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Denali Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- May 12, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 25 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2/3, multiregional, two-arm, double-blind, randomized, active (standard-of-care)-controlled study of the efficacy and safety of tividenofusp alfa (DNL310), an investigational central nervous system (CNS)-penetrant enzyme-replacement therapy (ERT) for mucopolysaccharidosis type II (MPS II). Participants may also qualify to enter an open-label treatment phase with DNL310 or idursulfase based on pre-specified criteria.
Conditions
- Mucopolysaccharidosis II
Interventions
tividenofusp alfaDrug
Intravenous repeating dose
idursulfaseDrug
Intravenous repeating dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ratio to baseline in cerebrospinal fluid (CSF) heparan sulfate (HS) concentration (Cohort A)Time frame: 24 weeks
- Change from baseline in the Vineland Adaptive Behavior Scale, Third Edition (Vineland-3)(Cohort A)Time frame: 96 weeks
Locations
30 sites in 14 countries. Site status is shown where the registry gives one.
UCSF Benioff Children's Hospital Oakland
Oakland, California
Ann and Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois
Hackensack University Medical Center
Hackensack, New Jersey
UNC Children's Research Institute
Chapel Hill, North Carolina
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
The University of Texas Medical School at Houston
Houston, Texas
University of Utah, PPDS
Salt Lake City, Utah
Sanatorio Mater Dei
Buenos Aires, Argentina
UZ Antwerpen
Antwerp, Antwerpen, Belgium
Universitair Ziekenhuis Brussel
Jette, Brussels Capital, Belgium
Hospital de Clínicas de Porto Alegre (HCPA) - PPDS
Porto Alegre, Brazil
University of Alberta - Faculty of Medicine & Dentistry
Edmonton, Alberta, Canada
Hospital for Sick Children
Toronto, Ontario, Canada
McGill University Health Center
Montreal, Quebec, Canada
Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
Hôpital Jeanne de Flandre
Lille, France
Medizinische Universität Lausitz - Carl Thiem
Cottbus, Germany
SphinCS
Höchheim, Hochheim, Germany
Azienda Sanitaria Universitaria Friuli Centrale - PO Universitario Santa Maria della Misericordia
Udine, Italy
Erasmus Medical Center - Sophia Children's Hospital
Rotterdam, Rotterdam, Netherlands
Hospital Universitario Vall d'Hebron
Barcelona, Barcelona, Spain
Hospital Infantil Universitario Niño Jesus
Madrid, Madrid, Spain
Drottning Silvias Barn Och Ungdomssjukhus
Gothenburg, Sweden
Cukurova University Medical Faculty Balcali Hospital
Adana, Turkey (Türkiye)
Gazi Universitesi Tip Fakultesi
Çankaya, Turkey (Türkiye)
Birmingham Women's and Children's NHS Foundation Trust
Birmingham, United Kingdom
Royal Free Hospital
London, United Kingdom
Salford Royal Hospital
Salford, United Kingdom
Great Ormond Street Hospital for Children
London, London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.